Instructional course lectures | 2024 | Houdek MT, Takeuchi A, Jeys L, Randall RL
Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.
[Indexed for MEDLINE] 3. Orthop Clin North Am. 2016 Jan;47(1):283-92. doi: 10.1016/j.ocl.2015.08.022. Update on Survival in Osteosarcoma. Anderson ME(1). Author information: (1)Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, USA; Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, USA. Electronic address: manders6@bidmc.harvard.edu. Osteosarcoma is the most common primary bone malignancy in children. Treatment has evolved to include systemic chemotherapy and local control surgery. Although survival improved initially in a drastic fashion with this approach, recent decades have seen little to no further gains in this area. Limb salvage surgery evolved with effective chemotherapy and advances in imaging, and continues to improve in the recent era. This article serves as a review of survival in high-grade osteosarcoma: prognostic factors, advances in chemotherapy and surgery, late effects of chemotherapy and surgery in survivors, and future directions. Copyright © 2016 Elsevier Inc. All rights reserved. DOI: 10.1016/j.ocl.2015.08.022
This article has not been linked to a wiki topic yet.
This article has not been linked to a case yet.
This article has not been linked to an atlas yet.
